Delivery Order SPE2DR25D1053-SPE2DR26FT212
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,135.25 to AmerisourceBergen Drug Corp for TALZENNA 0.5 mg softgels (30-count units) with a firm fixed price arrangement. The award, issued on September 4, 2025, is scheduled for completion by September 25, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate...
- The Defense Logistics Agency (DLA) awarded a $33,405.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Talzenna 0.5 mg softgel capsules (30-count units) on September 16, 2025, with an ultimate completion date of October 7, 2025. This non-set-aside, competitively awarded contract reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs. The contract represents a delivery order under...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for TALZENNA 0.35 mg softgel capsules (30-count supply) with a ceiling value of $11,135.25 and a firm fixed price structure. This non-set-aside, competitively awarded contract is scheduled for completion by October 15, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Talzenna 0.35 mg softgel capsules (30-count units) with a ceiling value of $11,135.25. This competitively awarded, firm fixed price delivery order is scheduled for completion by August 27, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $11,135.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Talzenna 0.25 mg softgel capsules (30-count units) on September 9, 2025, with a completion date of September 30, 2025. This competitively awarded, non-set-aside order will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,270.52 to AmerisourceBergen Drug Corp for the supply of Talzenna 0.35 mg softgel capsules (30-count units) under a firm fixed-price contract. The contract, awarded on September 15, 2025, with completion targeted for October 6, 2025, represents a non-competitive delivery order placement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 28, 2025, for the supply of Talzenna 0.5 mg softgels (30-count units) under a firm fixed-price contract with a ceiling value of $11.1K. This delivery order, which has no set-aside designation, represents a competitive award and is due for completion by October 20, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its...
- The U.S. Department of Defense's Medical Supply Chain awarded a $11,135.25 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Talzenna 0.35 mg softgel capsules (30-count units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by October 6, 2025. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with Defense Logistics Agency Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $11,135.25 to AmerisourceBergen Drug Corp for Talzenna 0.35 mg softgel capsules (30-count) with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger pharmaceutical supply contract vehicle...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of TALZENNA 0.5 MG CAPSULE 30S, a pharmaceutical product. The contract has a ceiling value of $21,568.70 and a period of performance through March 7, 2025. It is a firm fixed-price contract and does not have any set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT212Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for $11,734.84 to supply TALZENNA 0.35 mg softgel capsules in a quantity of 30 units. This is a firm fixed-price delivery order with no set-aside designation, demonstrating competitive award selection. The product will be delivered to the Conshohocken, Pennsylvania location by the ultimate completion date of November 13, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, is a critical vendor for federal medical procurement and serves military and veteran healthcare systems across multiple therapeutic domains. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables the company to supply a broad range of pharmaceutical products, medical supplies, specialty medications, vaccines, and related commodities to support Defense Health Agency and other federal healthcare programs worldwide. The company's extensive federal contract portfolio reflects its capability to fulfill competitive procurement requirements across diverse medical product categories and transaction values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.7k | 10/22/25 |